Department of Mechanical Engineering, University College London, London, WC1E 7JE, UK.
Department of Nanotechnology and Nanomedicine, Hacettepe University, Ankara, 06800, Turkey.
Macromol Biosci. 2021 Oct;21(10):e2100177. doi: 10.1002/mabi.202100177. Epub 2021 Jul 26.
The present study aspires towards fabricating core-sheath fibrous scaffolds by state-of-the-art pressurized gyration for bone tissue engineering applications. The core-sheath fibers comprising dual-phase poly-ε-caprolactone (PCL) core and polyvinyl alcohol (PVA) sheath are fabricated using a novel "co-axial" pressurized gyration method. Hydroxyapatite (HA) nanocrystals are embedded in the sheath of the fabricated scaffolds to improve the performance for application as a bone tissue regeneration material. The diameter of the fabricated fiber is 3.97 ± 1.31 µm for PCL-PVA/3%HA while pure PCL-PVA with no HA loading gives 3.03 ± 0.45 µm. Bead-free fiber morphology is ascertained for all sample groups. The chemistry, water contact angle and swelling behavior measurements of the fabricated core-sheath fibrous scaffolds indicate the suitability of the structures in cellular activities. Saos-2 bone osteosarcoma cells are employed to determine the biocompatibility of the scaffolds, wherein none of the scaffolds possess any cytotoxicity effect, while cell proliferation of 94% is obtained for PCL-PVA/5%HA fibers. The alkaline phosphatase activity results suggest the osteogenic activities on the scaffolds begin earlier than day 7. Overall, adaptations of co-axial pressurized gyration provides the flexibility to embed or encapsulate bioactive substances in core-sheath fiber assemblies and is a promising strategy for bone healing.
本研究旨在通过先进的加压旋转技术制造用于骨组织工程应用的核壳纤维支架。核壳纤维由双相聚己内酯(PCL)核和聚乙烯醇(PVA)鞘组成,采用新型“同轴”加压旋转方法制造。将羟基磷灰石(HA)纳米晶体嵌入到所制备的支架的鞘中,以提高其作为骨组织再生材料的性能。对于 PCL-PVA/3%HA,所制备纤维的直径为 3.97±1.31μm,而不含 HA 负载的纯 PCL-PVA 给出 3.03±0.45μm。所有样品组都确定了无珠纤维形态。所制备的核壳纤维支架的化学、水接触角和溶胀行为测量表明了这些结构在细胞活性中的适用性。Saos-2 骨肉瘤细胞用于确定支架的生物相容性,其中没有支架具有任何细胞毒性作用,而 PCL-PVA/5%HA 纤维获得了 94%的细胞增殖。碱性磷酸酶活性结果表明支架上的成骨活性早于第 7 天开始。总体而言,同轴加压旋转的适应性提供了在核壳纤维组件中嵌入或封装生物活性物质的灵活性,是骨愈合的有前途的策略。